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Background
In correlative studies HLA class I type is consistently
found to have the strongest impact on HIV disease
progression. However, the exact mechanism involved
is complicated by several factors; many alleles are
ligands for NK cells as well as CD8 T-cells, and strong
linkage disequilibrium between Class I alleles makes it
difficult to distinguish the effect of individual alleles
from other HLAs or from other important loci found
on the HLA haplotype, such as the recently described
-35 SNP.
Methods
Here we study two recently diverged HLA alleles,
B*4201 and B*4202, which only differ by a single
amino acid. Crucially, they occur primarily on identical
Class I haplotypes and do not act as NK cell ligands.
Therefore, they represent a unique opportunity to
study the impact of a single HLA allele on HIV
immune control not confounded by other genetic fac-
tors in a large outbred cohort (n=2,093) of C-clade
infected individuals.
Results
Here we show that the amino acid change in position
9 of the HLA-B molecule, is critical for peptide binding
and significantly alters the Gag CTL epitopes targeted
(P=2x10-10), measured both directly ex-vivo by
ELISPOT and indirectly through CTL escape mutation
(P=2x10-8). Strikingly, HLA-B*4201 is associated with
significantly lower viral load setpoint than HLA-B*4202
(P=0.02).
Conclusion
This naturally controlled experiment represents perhaps
the clearest demonstration of the direct impact of particular
HIV Gag specific CTL on disease control.
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